Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.

about

Dendritic cell vaccination.Dendritic cell-based vaccine research against cancer.Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.Distinct features of dendritic cell-based immunotherapy as cancer vaccines.

P2860

Q36899104-4C169715-0B74-4CA8-B91E-C97381F407F0 Q38281782-A22B0E07-A84F-4C6A-BD2E-71C86860C445 Q40016567-609E8EE1-D460-4BF8-8B67-6D18EA79B9F1 Q48109150-A46AA52D-76C1-4B2F-8A78-F6233AD51F24

P2860

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.

Item

http://www.wikidata.org/entity/Q45880822

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@en

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@nl

type

Item

label

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@en

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@nl

prefLabel

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@en

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@nl

P1476

Ex vivo generation of genetica ...... s of lymphocyte contamination.

@en

P2093

Chinnasamy D

http://www.w3.org/2001/XMLSchema#string

Chinnasamy N

http://www.w3.org/2001/XMLSchema#string

Hanson JP

http://www.w3.org/2001/XMLSchema#string

Oaks MK

http://www.w3.org/2001/XMLSchema#string

Treisman JS

http://www.w3.org/2001/XMLSchema#string

P2860

The dendritic cell system and its role in immunogenicity

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.

Dendritic cells: therapeutic potentials.

Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Gene-modified dendritic cells for use in tumor vaccines.

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Viral vectors for dendritic cell-based immunotherapy.

Clinical applications of dendritic cell vaccination in the treatment of cancer.

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

P2888

sj.gt.3302407

P304

259-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3302407

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8062440

http://www.w3.org/2001/XMLSchema#string

P6179

1037667863

http://www.w3.org/2001/XMLSchema#string

P698

15668698

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

lymphocyte

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.

about

P2860

P2860

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921